CO2 Modulation in Endovascular Thrombectomy for Acute Ischemic Stroke

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE2

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-07-20

Study Completion Date

2026-10-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Acute ischemic stroke due to large vessel occlusion is responsible of cerebral blood flow impairment with a progressive and extensive ischemic process. Cerebral collateral circulation may preserve an ischemic penumbra that could recover providing timely reperfusion of the occluded vessel. Mechanical thrombectomy is the standard of care for anterior circulation large vessel reperfusion. Strategy to promote cerebral blood flow in collateral circulation before reperfusion is scarce and rely mainly on blood pressure maintenance. Carbon dioxide is a potent cerebral vasodilator that could enhance collateral circulation blood flow and cerebral protection before reperfusion. General anesthesia with endotracheal mechanical ventilation could be used for thrombectomy and give the opportunity to modulate and control carbon dioxide tension in the blood. This study will test the effect of moderate hypercapnia on penumbral collateral circulation before reperfusion during mechanical thrombectomy for anterior circulation acute ischemic stroke under general anesthesia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Anesthesia Management in Endovascular Therapy for Ischemic Stroke

NCT03229148

Stroke Thrombectomy Anesthesia +1 more

COMPLETED NA

Effect of Proximal Blood Flow Arrest During Endovascular Thrombectomy

NCT05020795

Stroke Occlusion, Cerebrovascular

COMPLETED NA

Neurothrombectomy France

NCT02880579

Cerebral Artery Occlusion

COMPLETED

Which Factors Influence the Duration and the Success of Mechanical Thrombectomy During the Acute Phase of Cerebral Infarction?

NCT03451903

Acute Stroke

COMPLETED

Anesthesia Management in Endovascular Therapy for Ischemic Stroke - 2

NCT07235514

Ischemic Stroke Anterior Cerebral Circulation General Anesthesia +2 more

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study will compare 2 groups of patients treated for anterior circulation large vessel occlusion stroke thrombectomy under general anesthesia.

After anesthetic evaluation, patients will be randomized to receive moderate hypercapnia targeting an arterial CO2 tension (PaCO2) of 50mmHg or normocapnia targeting a PaCO2 of 40mmHg.

The anesthetic protocol will use:

* Rapid sequence induction for orotracheal intubation with PROPOFOL 2mg/Kg and SUXAMETHONIUM 1mg/Kg
* SUFENTANIL 0,1 µg/Kg and CISATRACURIUM 0,1mg/Kg
* Maintenance with intravenous continuous infusion of PROPOFOL targeting a BISpectral index 40 to 60
* Systolic blood pressure will have to be maintained +/- 10% of preoperative baseline value with limits between 120 and 185mmHg (with NOREPINEPHRINE as needed)
* Mechanical ventilation will use Tidal Volume of 7mL/Kg of ideal body weight, respiratory rate of 15/minute, End expiratory pressure of 5cmH2O. FiO2 will target SpO2 95-98%. Initial End Tidal CO2 (EtCO2) target will be 35mmHg.
* A first arterial blood gas analysis at groin puncture will evaluate CO2 alveolar-arterial gradient in order to obtain the expected PaCO2 in each group with respiratory rate modulation on the ventilator.
* ASITN baseline collaterality score will be evaluated at initial angiography with normocapnia in each group. A second evaluation of ASITN will be done just before deployment of intraarterial revascularisation device in hypercapnia or normocapnia depending on randomisation group.
* Targeted PaCO2 will have to be maintained using EtCO2 surrogate until the end of procedure.
* A second arterial blood gas analysis at the end of procedure will evaluate final PaCO2.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ischemic Stroke, Acute Thrombectomy Anesthesia, General Cerebrovascular Circulation Carbon Dioxide

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HYPERCAPNIA

Under general anesthesia with mechanical ventilation, PaCO2=50mmHg will be targeted

Group Type EXPERIMENTAL

HYPERCAPNIA

Intervention Type BIOLOGICAL

Controlled moderate hypercapnia PaCO2 50mmHg under general anesthesia with mechanical ventilation

NORMOCAPNIA

Under general anesthesia with mechanical ventilation, PaCO2=40mmHg will be targeted

Group Type ACTIVE_COMPARATOR

NORMOCAPNIA

Intervention Type BIOLOGICAL

Controlled normocapnia PaCO2 40mmHg under general anesthesia with mechanical ventilation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HYPERCAPNIA

Controlled moderate hypercapnia PaCO2 50mmHg under general anesthesia with mechanical ventilation

Intervention Type BIOLOGICAL

NORMOCAPNIA

Controlled normocapnia PaCO2 40mmHg under general anesthesia with mechanical ventilation

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

• Large vessel occlusion anterior circulation stroke (terminal carotid artery and/or middle cerebral artery M1-M2 segment) eligible to mechanical thrombectomy under general anesthesia

Exclusion Criteria

* Active smoker
* Chronic respiratory failure with ambulatory oxygen supplementation
* Obesity with BMI\>40Kg/ m2
* Intubation before the procedure
* Heart failure with intolerance to decubitus
* Severe renal failure
* Suspected elevated intracranial pressure
* Pregnant or breastfeeding women

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No